Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Daley

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Nature Biotechnology|July 9, 2014
Access all areasJohn Daley, Alicia Shiu
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2002
Fas-dependent elimination of nonselected CD8 cells and lpr diseaseLinda A Trimble, Kenya A Prince, Gary A Pestano, et al.
Cytotechnology|May 29, 2017
Development of an 8-color antibody panel for functional phenotyping of human CD8+ cytotoxic T cells from peripheral blood mononuclear cellsTara Patel, Amy Cunningham, Martha Holland, et al.
British Journal of Haematology|April 27, 2012
A novel immunogenic CS1-specific peptide inducing antigen-specific cytotoxic T lymphocytes targeting multiple myelomaJooeun Bae, Weihua Song, Robert Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2012
Myeloma-specific multiple peptides able to generate cytotoxic T lymphocytes: a potential therapeutic application in multiple myeloma and other plasma cell disordersJooeun Bae, Robert Smith, John Daley, et al.
Communications Biology|June 8, 2024
Immune profiling of age and adjuvant-specific activation of human blood mononuclear cells in vitroSimone S Schüller, Soumik Barman, Raul Mendez-Giraldez, et al.
Blood|November 17, 2007
SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphomaLinfeng Chen, Stefano Monti, Przemyslaw Juszczynski, et al.
British Journal of Haematology|June 13, 2002
Combination immunotherapy with rituximab and interleukin 2 in patients with relapsed or refractory follicular non-Hodgkin's lymphomaJonathan W Friedberg, Donna Neuberg, John G Gribben, et al.
Blood|February 8, 2007
Protein kinase C inhibitor enzastaurin induces in vitro and in vivo antitumor activity in Waldenstrom macroglobulinemiaAnne-Sophie Moreau, Xiaoying Jia, Hai T Ngo, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Nature Biotechnology|July 9, 2014
Access all areasJohn Daley, Alicia Shiu
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2002
Fas-dependent elimination of nonselected CD8 cells and lpr diseaseLinda A Trimble, Kenya A Prince, Gary A Pestano, et al.
Cytotechnology|May 29, 2017
Development of an 8-color antibody panel for functional phenotyping of human CD8+ cytotoxic T cells from peripheral blood mononuclear cellsTara Patel, Amy Cunningham, Martha Holland, et al.
British Journal of Haematology|April 27, 2012
A novel immunogenic CS1-specific peptide inducing antigen-specific cytotoxic T lymphocytes targeting multiple myelomaJooeun Bae, Weihua Song, Robert Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2012
Myeloma-specific multiple peptides able to generate cytotoxic T lymphocytes: a potential therapeutic application in multiple myeloma and other plasma cell disordersJooeun Bae, Robert Smith, John Daley, et al.
Communications Biology|June 8, 2024
Immune profiling of age and adjuvant-specific activation of human blood mononuclear cells in vitroSimone S Schüller, Soumik Barman, Raul Mendez-Giraldez, et al.
Blood|November 17, 2007
SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphomaLinfeng Chen, Stefano Monti, Przemyslaw Juszczynski, et al.
British Journal of Haematology|June 13, 2002
Combination immunotherapy with rituximab and interleukin 2 in patients with relapsed or refractory follicular non-Hodgkin's lymphomaJonathan W Friedberg, Donna Neuberg, John G Gribben, et al.
Blood|February 8, 2007
Protein kinase C inhibitor enzastaurin induces in vitro and in vivo antitumor activity in Waldenstrom macroglobulinemiaAnne-Sophie Moreau, Xiaoying Jia, Hai T Ngo, et al.
Pageof 1